{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:14:32Z","timestamp":1760782472516,"version":"3.37.3"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2002,8]]},"DOI":"10.1124\/jpet.102.033886","type":"journal-article","created":{"date-parts":[[2003,1,10]],"date-time":"2003-01-10T18:44:00Z","timestamp":1042224240000},"page":"612-618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Molecular Actions of (S)-Desmethylzopiclone (SEP-174559), an Anxiolytic Metabolite of Zopiclone"],"prefix":"10.1016","volume":"302","author":[{"given":"Mark W.","family":"Fleck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.102.033886_bib1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0031-6997(24)01363-2","article-title":"International Union of Pharmacology. XV. Subtypes of GABAA receptors: classification on the basis of subunit structure and receptor function.","volume":"50","author":"Barnard","year":"1998","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.102.033886_bib2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0014-2999(01)00851-2","article-title":"Sedative and anxiolytic effects of zopiclone\u2019s enantiomers and metabolite.","volume":"415","author":"Carlson","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.102.033886_bib3","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0026-895X(24)23107-2","article-title":"Characterization of the interaction of zopiclone with GABA type-A receptors.","volume":"58","author":"Davies","year":"2000","journal-title":"Mol Pharm"},{"key":"10.1124\/jpet.102.033886_bib4","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/cne.903590111","article-title":"GABAA-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits.","volume":"359","author":"Fritschy","year":"1995","journal-title":"J Comp Neurol"},{"issue":"Suppl 2","key":"10.1124\/jpet.102.033886_bib5","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000137914","article-title":"Pharmacokinetics and metabolism of zopiclone.","volume":"27","author":"Gaillot","year":"1983","journal-title":"Pharmacol"},{"key":"10.1124\/jpet.102.033886_bib6","doi-asserted-by":"crossref","first-page":"7749","DOI":"10.1073\/pnas.92.17.7749","article-title":"Benzodiazepine-insensitive mice generated by targeted disruption of the \u03b32 subunit gene of \u03b3-aminobutyric acid type-A receptors.","volume":"92","author":"Gunther","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.102.033886_bib7","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0026-895X(25)13278-1","article-title":"Potentiation of GABA-induced chloride currents by various benzodiazepine site agonists with the \u03b11\u03b32, \u03b22\u03b32 and \u03b11\u03b22\u03b32 subtypes of cloned GABAA receptors.","volume":"44","author":"Im","year":"1993","journal-title":"Mol Pharm"},{"key":"10.1124\/jpet.102.033886_bib8","first-page":"77","article-title":"The mechanism of action and pharmacology of zopiclone.","volume":"9","author":"Karle","year":"1998","journal-title":"Rev Contemp Pharmacother"},{"key":"10.1124\/jpet.102.033886_bib9","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1523\/JNEUROSCI.12-03-01040.1992","article-title":"The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. II. Olfactory bulb and cerebellum.","volume":"12","author":"Laurie","year":"1992","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.102.033886_bib10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1126\/science.290.5489.131","article-title":"Molecular and neuronal substrate for the selective attenuation of anxiety.","volume":"290","author":"Low","year":"2000","journal-title":"Science (Wash DC)"},{"key":"10.1124\/jpet.102.033886_bib11","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/75761","article-title":"Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor \u03b11 subtype.","volume":"3","author":"McKernan","year":"2000","journal-title":"Nat Neurosci"},{"key":"10.1124\/jpet.102.033886_bib12","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0165-0173(98)00052-6","article-title":"An update on GABAA receptors.","volume":"29","author":"Mehta","year":"1999","journal-title":"Brain Res Rev"},{"key":"10.1124\/jpet.102.033886_bib13","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/0304-3940(90)90133-T","article-title":"Cyclopyrrolones, unlike some benzodiazepines, do not induce physical dependence in mice.","volume":"117","author":"Piot","year":"1990","journal-title":"Neurosci Lett"},{"key":"10.1124\/jpet.102.033886_bib14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0014-2999(96)00527-4","article-title":"Propofol and flurazepam act synergistically to potentiate GABAA receptor activation in human recombinant receptors.","volume":"314","author":"Reynolds","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.102.033886_bib15","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/44579","article-title":"Benzodiazepine actions mediated by specific GABAA receptor subtypes.","volume":"401","author":"Rudolph","year":"1999","journal-title":"Nature (Lond)"},{"key":"10.1124\/jpet.102.033886_bib16","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0149-7634(94)90049-3","article-title":"Recent developments in the behavioral pharmacology of benzodiazepine (\u03c9) receptors: evidence for the functional significance of receptor subtypes.","volume":"18","author":"Sanger","year":"1994","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1124\/jpet.102.033886_bib17","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0165-6147(97)90675-1","article-title":"The benzodiazepine binding site of GABAA receptors.","volume":"18","author":"Sigel","year":"1997","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.102.033886_bib18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0031-6997(25)06840-1","article-title":"Structure and pharmacology of GABAA receptor subtypes.","volume":"47","author":"Sieghart","year":"1995","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.102.033886_bib19","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1523\/JNEUROSCI.12-03-01040.1992","article-title":"The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon.","volume":"12","author":"Wisden","year":"1992","journal-title":"J Neurosci"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524358070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524358070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.102.033886","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T23:24:25Z","timestamp":1740007465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524358070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,8]]}},"alternative-id":["S0022356524358070"],"URL":"https:\/\/doi.org\/10.1124\/jpet.102.033886","relation":{},"ISSN":["0022-3565"],"issn-type":[{"type":"print","value":"0022-3565"}],"subject":[],"published":{"date-parts":[[2002,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular Actions of (S)-Desmethylzopiclone (SEP-174559), an Anxiolytic Metabolite of Zopiclone","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.102.033886","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2002 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}